The estimated Net Worth of Robert Studholme is at least $969 Tisíc dollars as of 10 March 2023. Robert Studholme owns over 8,859 units of Staar Surgical Co stock worth over $969,314 and over the last 2 years Robert sold STAA stock worth over $0.
Robert has made over 2 trades of the Staar Surgical Co stock since 2023, according to the Form 4 filled with the SEC. Most recently Robert exercised 8,859 units of STAA stock worth $268,516 on 10 March 2023.
The largest trade Robert's ever made was exercising 8,859 units of Staar Surgical Co stock on 10 March 2023 worth over $268,516. On average, Robert trades about 5,284 units every 2 days since 2023. As of 10 March 2023 Robert still owns at least 31,980 units of Staar Surgical Co stock.
You can see the complete history of Robert Studholme stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is 25651, Atlantic Ocean Drive, Lake Forest, Orange County, California, 92630, United States.
Over the last 21 years, insiders at Staar Surgical Co have traded over $305,974,767 worth of Staar Surgical Co stock and bought 10,576,326 units worth $122,359,752 . The most active insiders traders include Partners, L.P.Broadwood Cap..., Partners, L.P.Bradsher Neal... a Gilbert H Kliman. On average, Staar Surgical Co executives and independent directors trade stock every 26 days with the average trade being worth of $1,643,742. The most recent stock trade was executed by Arthur C Butcher on 12 August 2024, trading 1,315 units of STAA stock currently worth $49,957.
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad
Staar Surgical Co executives and other stock owners filed with the SEC include: